MedPath

Evaluating the Effect of Subcutaneous Dexamethasone Added to Bupivacaine on Postcesarean Pain Relief

Phase 4
Conditions
Complications of anaesthesia during pregnancy.
Other complications of anaesthesia during pregnancy
Registration Number
IRCT138809242405N3
Lead Sponsor
Isfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
75
Inclusion Criteria

Inclusion Criteria: Parturients, ASA physical status I-II, scheduled for elective cesarean section, under general anesthesia.

Exclusion Criteria

patients with suspected or manifest bleeding disturbances, allergy to Bupivacaine or Dexamethasone, atopia, diabetes mellitus, the presence of liver or kidney diseases, abuse of drugs and patients with pregnant induced hypertension or preeclampsia.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain intensity. Timepoint: recovery room ,6 , 12, 24, 48 and 72 hours postoperative. Method of measurement: Visual Analogous Scale (VAS) and scoring from 0 to 10.
Secondary Outcome Measures
NameTimeMethod
Systolic blood pressure. Timepoint: at recovery room ,6 , 12, 24, 48 and 72 hours postoperative. Method of measurement: using mercury manometer.;Diastolic blood pressure. Timepoint: at recovery room ,6 , 12, 24, 48 and 72 hours postoperative. Method of measurement: using mercury manometer.;Opioid consumption. Timepoint: at recovery room ,6 , 12, 24, 48 and 72 hours postoperative. Method of measurement: mili gram of opioid.;Heart rate. Timepoint: at recovery room ,6 , 12, 24, 48 and 72 hours postoperative. Method of measurement: Using EKG Monitoring.
© Copyright 2025. All Rights Reserved by MedPath